Skip to main content

Hyponatremia, euvolemic News

Treatment Initiation With Thiazide Diuretics Increases Hyponatremia Risk

MONDAY, Dec. 18, 2023 – The excess risk for hyponatremia is increased with treatment initiation with thiazide diuretics, according to a study published online Dec. 19 in the Annals of Internal...

FDA Medwatch Alert: Samsca (Tolvaptan): Drug Safety Communication - FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death

ISSUE: FDA has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver...

Ask a question

To post your own question to this support group, sign in or create an account.